Quoin Pharmaceuticals Ltd Stock Today
| QNRX Stock | USD 0.62 0.02 3.13% |
Performance6 of 100
| Odds Of DistressLess than 49
|
Quoin Pharmaceuticals is trading at 0.62 as of the 13th of November 2024; that is 3.13 percent decrease since the beginning of the trading day. The stock's open price was 0.64. Quoin Pharmaceuticals has 49 percent odds of going through some form of financial distress in the next two years and did not have a very good performance for investor during the last 90 trading days. Equity ratings for Quoin Pharmaceuticals Ltd are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 14th of September 2024 and ending today, the 13th of November 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 29th of July 2016 | Category Healthcare | Classification Health Care |
Quoin Pharmaceuticals, Ltd., a clinical stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases. Quoin Pharmaceuticals, Ltd. was incorporated in 2018 and is based in Ashburn, Virginia. The company has 5.05 M outstanding shares of which 478.43 K shares are at this time shorted by private and institutional investors with about 0.2 trading days to cover. More on Quoin Pharmaceuticals Ltd
Moving against Quoin Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Quoin Stock Highlights
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | ||||
| Average Analyst Recommendation | |||||
Debt LevelsQuoin Pharmaceuticals can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Quoin Pharmaceuticals' financial leverage. It provides some insight into what part of Quoin Pharmaceuticals' total assets is financed by creditors.
| |||||
Quoin Pharmaceuticals Ltd (QNRX) is traded on NASDAQ Exchange in USA. It is located in 42127 Pleasant Forest Court, Ashburn, VA, United States, 20148-7349 and employs 4 people. Quoin Pharmaceuticals is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.13 M. Quoin Pharmaceuticals conducts business under Biotechnology sector and is part of Health Care industry. The entity has 5.05 M outstanding shares of which 478.43 K shares are at this time shorted by private and institutional investors with about 0.2 trading days to cover.
Quoin Pharmaceuticals Ltd currently holds about 2.69 M in cash with (7.84 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.56.
Check Quoin Pharmaceuticals Probability Of Bankruptcy
Ownership AllocationRoughly 91.68 pct. of Quoin Pharmaceuticals outstanding shares are held by general public with 2.44 % owned by insiders and only 5.88 (%) by third-party entities.
Check Quoin Ownership Details
Quoin Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Virtu Financial Llc | 2024-06-30 | 0.0 | |
| Hrt Financial Llc | 2024-06-30 | 0.0 | |
| Altium Capital Management, Lp | 2024-06-30 | 103.1 K | |
| Renaissance Technologies Corp | 2024-06-30 | 34.2 K | |
| Raymond James Finl Svs Advisors, Inc. | 2024-09-30 | 25.1 K | |
| Two Sigma Securities, Llc | 2024-06-30 | 23.5 K | |
| Susquehanna International Group, Llp | 2024-06-30 | 15.4 K | |
| Rhumbline Advisers | 2024-06-30 | 14.8 K | |
| Two Sigma Investments Llc | 2024-06-30 | 10.9 K | |
| Resources Investment Advisors Inc | 2024-06-30 | 10.4 K | |
| Ubs Group Ag | 2024-06-30 | 6.1 K |
Quoin Pharmaceuticals Historical Income Statement
Quoin Stock Against Markets
Additional Tools for Quoin Stock Analysis
When running Quoin Pharmaceuticals' price analysis, check to measure Quoin Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quoin Pharmaceuticals is operating at the current time. Most of Quoin Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Quoin Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quoin Pharmaceuticals' price. Additionally, you may evaluate how the addition of Quoin Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.